Amar Nath Bhandary, 53, from Oklahoma was sentenced to 30 months in prison, followed by three years supervised release and a USD 20,000 fine, US Attorney for the Western District of Oklahoma Sanford Coats said in a statement.
Bhandary has also been ordered to pay restitution to Medicare and forfeit some property.
A case was filed against him in May this year alleging that Bhandary engaged in healthcare fraud in 2008 by submitting false claims to Medicare for services that he had not provided.
He was also indicted in March last year by a federal grand jury in a 53-count indictment alleging illegal distribution of controlled substances.
The indictment also alleged that Bhandary distributed various controlled drugs to eight separate individuals illegally in 2008 and 2009. The complaint said five of these individuals died from drug toxicity.
In April this year, a jury trial was held in Oklahoma City federal court. However, the jury was unable to reach a verdict.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
